In April, the FDA warned Pfizer of "significant violations" involving pediatric trials of Geodon that were found during inspections of several clinical investigators involved in the studies. The agency said there was " widespread overdosing" of patients as a result of inadequate monitoring by Pfizer.
via nasdaq.com
No comments:
Post a Comment